StepWise USMLE
pancreatic pathology · high‑yield

Pancreas
in focus

Congenital · inflammatory · neoplastic — core concepts for clinical reasoning

🧬 Congenital anomalies

  • agenesis Complete absence of pancreas → incompatible with life.
  • pancreas divisum Most common ductal variant: dorsal and ventral ducts fail to fuse.
    • Usually asymptomatic, but may predispose to recurrent pancreatitis.
  • annular pancreas Pancreatic tissue encircles the duodenum.
    • Presents as duodenal obstruction (neonatal or adult).
    • Associated with other congenital anomalies (e.g., Down syndrome).
  • ectopic tissue Aberrant pancreatic rests in stomach, duodenum, or jejunum.
    • Can hemorrhage, become inflamed, or rarely give rise to neuroendocrine tumors.
  • Annular pancreas can be suspected on plain X‑ray as “double‑bubble” sign in neonates.

🔥 Acute pancreatitis

  • definition Acute inflammation of the exocrine pancreas with enzymatic autodigestion.
  • etiologies Diverse triggers:
    • Gallstones (most common)
    • Alcohol (second most common)
    • Hypercalcemia, hypertriglyceridemia
    • Drugs (e.g., sulfonamides, valproate)
    • Shock, ischemia, trauma, infections (mumps, Coxsackie)
    • Scorpion stings (rare)
  • pathogenesis Acinar injury → premature activation of trypsinogen → pancreatic enzyme cascade.
    Acinar injury→ Trypsin activation→ Autodigestion→ Inflammation + necrosis
  • clinical Stabbing epigastric pain radiating to the back; nausea, vomiting.
    • Severe cases: shock, ARDS, DIC, renal failure.
  • labs Elevated serum amylase and lipase (lipase more specific).
  • complications
    • Pancreatic pseudocyst (fluid collection without epithelial lining).
    • Pancreatic calcifications, hypocalcemia (fat saponification).
    • ARDS, DIC, multi‑organ failure.
  • pathology Gross: focal hemorrhage, liquefaction, chalky white‑yellow fat necrosis.
    • Micro: liquefactive necrosis, acute inflammation, enzymatic fat necrosis.
    • Vessel necrosis → hemorrhage.
  • Mortality in severe acute pancreatitis: ~30% — early recognition is critical.

⏳ Chronic & autoimmune pancreatitis

  • chronic pancreatitis Irreversible fibrosis, atrophy, and functional loss.
    • Most common in middle‑aged male alcoholics.
    • Manifestations: abdominal pain, malabsorption, pancreatic calcifications, pseudocyst, secondary diabetes (late).
  • pathology Gross: firm, white, fibrotic pancreas. Micro: extensive fibrosis, parenchymal atrophy, chronic inflammation.
  • autoimmune Associated with IgG4‑related fibrosing disorders.
    • Responds to steroid therapy.
    • May present with obstructive jaundice (mimics pancreatic cancer).
  • Secondary diabetes in chronic pancreatitis is due to islet cell destruction — not insulin resistance.

🧫 Neuroendocrine tumors (islet cell)

  • Less common than exocrine tumors. Most are low‑grade malignancies.
    • Some are non‑functional (no hormone excess).
    • Gross/histology does not distinguish subtypes.
TumorCell / hormoneKey features
Insulinomaβ‑cell / insulinHypoglycemia, sweating, confusion; surgical cure.
GastrinomaG‑cell / gastrinZollinger‑Ellison (thick gastric folds, hyperacidity, ulcers); may be extrapancreatic; associated with MEN1.
Glucagonomaα‑cell / glucagonHyperglycemia, anemia, necrolytic migratory erythema.
Somatostatinomaδ‑cell / somatostatinDiabetes (inhibits insulin), hypochlorhydria, gallstones, steatorrhea; poor prognosis.
VIPomaVIPWDHA: Watery diarrhea, Hypokalemia, Achlorhydria.

🧬 Adenocarcinoma

  • epidemiology 3rd most common cause of cancer death in the US. Age 60–80.
  • risk factors Smoking, chronic pancreatitis, diabetes, family history.
  • presentation Vague until late. Later: abdominal pain, migratory thrombophlebitis (Trousseau), obstructive jaundice (head tumors).
  • location Head (60%), body (15%), tail (5%).
  • pathology Ductal adenocarcinoma with desmoplasia and perineural invasion (hallmark).
    • Markers: CA19‑9, CEA (not for screening).
  • treatment Surgical excision (Whipple procedure) for localized disease.
  • prognosis Very poor; 5‑year survival ~5%.
  • Perineural invasion is a classic feature and contributes to pain and high recurrence.

🫧 Cystic neoplasms

  • serous ~25% of pancreatic cystic neoplasms. Mostly benign (cystadenoma).
    • Associated with VHL mutation.
  • mucinous cystic neoplasm Common in women; can harbor dysplasia or carcinoma.
    • Distal pancreatectomy is curative in most.
  • intraductal papillary mucinous neoplasm (IPMN) More common in men, arises in the head.
    • GNAS mutations frequent; risk of invasive carcinoma.
  • IPMN is a premalignant lesion — surveillance or resection based on risk features.